Clinical Trials Directory

Trials / Completed

CompletedNCT01567852

Use of Ketamine vs Methohexital for Electroconvulsive Therapy (ECT) on Patient Recovery and Re-orientation Time

The Use of Ketamine Versus Methohexital for Electroconvulsive Therapy: A Cross-Over Comparative Study on Patient Recovery and Re-Orientation Time

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
University of New Mexico · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

When undergoing ECT treatments, patient recovery time and re-orientation time may be shorter using ketamine for induction than using methohexital.

Detailed description

ECT treatments are done under general anesthesia, and the induction is commonly done with methohexital. We will study whether using ketamine as an induction agent will result in a faster recovery time and quicker re-orientation time compared to using methohexital.

Conditions

Interventions

TypeNameDescription
DRUGKetamineKetamine (1.5mg/kg) will be given for induction, with room to titrate up to induction effect
DRUGMethohexitalMethohexital (1.5mg/kg) will be given for induction

Timeline

Start date
2011-08-01
Primary completion
2013-03-01
Completion
2013-03-01
First posted
2012-03-30
Last updated
2014-12-30
Results posted
2014-12-30

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01567852. Inclusion in this directory is not an endorsement.